Amanote Research
Register
Sign In
Busulfan and Cyclophosphamide (BU/CY2) as Preparative Regimen for Patients With Lymphoma
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/sj.bmt.1700733
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
April 1, 1997
Authors
M deMagalhaes-Silverman
J Lister
W Rybka
J Wilson
E Ball
Publisher
Springer Science and Business Media LLC
Related search
Busulfan Fludarabine vs Busulfan Cyclophosphamide as a Preparative Regimen Before Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis
Bone Marrow Transplantation
Transplantation
Hematology
Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine as a Preparative Regimen for Allogeneic Haemopoietic Stem-Cell Transplantation in Patients With Acute Myeloid Leukaemia: An Open-Label, Multicentre, Randomised, Phase 3 Trial
The Lancet Oncology
Oncology
BU, Melphalan and Thiotepa as a Preparative Regimen for Auto-Transplantation in Hodgkin’s Disease
Bone Marrow Transplantation
Transplantation
Hematology
Late Effects Following Hematopoietic Stem Cell Transplant With Busulfan-Based Preparative Regimen in Fanconi Anemia
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Autologous SCT With a Dose-Reduced BU and CY Regimen in Older Patients With Non-Hodgkin's Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Fludarabine and Busulfan Versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Thiotepa, Busulfan and Fludarabine Compared to Busulfan and Cyclophosphamide as Conditioning Regimen for Allogeneic Stem Cell Transplant From Matched Siblings and Unrelated Donors for Acute Myeloid Leukemia
American Journal of Hematology
Hematology
High-Dose Chemotherapy With Thiotepa, Busulfan, and Cyclophosphamide and Autologous Stem Cell Transplantation for Patients With Primary Central Nervous System Lymphoma in First Complete Remission
Cancer
Cancer Research
Oncology
Intermediate-Dose Busulfan and Cyclophosphamide as a Conditioning Regimen for Bone Marrow Transplantation in a Case of Fanconi Anemia in Myelodysplastic Transformation
Bone Marrow Transplantation
Transplantation
Hematology
